; however the majority of valves were used within the first week.
quire matching the size and shape of the components of the homograft to those of the host. All patients were followed up at regular intervals at our hospital with clinical, radiographic and electrocardiographic examination except in 27 instances when follow-up data were obtained from the referring physician. The followup period extended from 3 to 84 months (mean 35 months). Repeat cardiac catheterization was performed in 74 patients randomly selected 6 months to 51/2 years after operation.
Results

Early and Late Mortality
There were 11 deaths within the first four weeks after operation, an early mortality rate of 3.2%. Twenty-three patients died within the follow-up period, a late mortality rate of 6.8%. Actuarial analysis of survival (using the method described by Berksen and 5 ).
Infective endocarditis caused valve failure in three patients. The organism was bacterial in one and fungal in two. This complication was encountered in the first two years with an incidence of 0.7% of patients at risk during the first year and 0.4% of those at risk during the second year. The overall incidence of endocarditis is discussed later.
Calcification of the homograft leading to stenosis and regurgitation occurred in five patients. This occurred after the fourth year with an incidence of 3.6% of the patients at risk ( fig. 5 ). In each of the five cases the valve used was obtained from a donor over the age of 70 years.
Seven patients successfully underwent repeat valve replacement using another homograft valve.
Postoperative Aortic Regurgitation
Diastolic murmurs indicative of a degree of aortic regurgitation were recorded in 72 (22%) of 328 patients who were followed up for a minimum period of one month. The murmurs were generally first recorded during the first year. The incidence increased slightly as the follow-up period lengthened ( fig. 6 ). Repeat catheterization to quantify the amount of regurgitation was not performed except in patients who were judged clinically to have a severe hemodynamic lesion. The aortic regurgitation was clinically trivial to mild in 52 (15.9%), moderate in 13 (4%) and severe in seven (2.1 %). At 5 years the incidence of severe regurgitation was 1.2% of patients at risk while that of moderate regurgitation was 3.7% ( fig. 6 ).
Systolic Murmurs
Systolic murmurs were observed frequently. The gradient across the aortic valve in 74 patients, measured at periods between 6 months and 5/2 years after operation, did not exceed 10 mm Hg in any patient and was 0 both at rest and exercise in 72. The five patients with stenosis of the homograft due to calcification, referred to earlier, had gradients varying from 40-70 mm Hg.
Systemic Embolism
Systemic embolism did not occur. Routine anticoagulation was not used.
Infective Endocarditis
Ten patients (3%) developed infective endocarditis, five fungal and five bacterial. Bacterial endocarditis occurred shortly after operation in two, within the first year in one and within the second year in one. The infection followed dental treatment in one. One of these died suddenly during antibiotic treatment. Three were cleared bacteriologically but developed signs of valve failure which was successfully treated by repeat homograft valve replacement. Of the five patients who developed Candida endocarditis four died and one was treated successfully using a combination of 5-fluorocytosine and intravenous amphoteracin B for a period of 12 weeks.
Clinical Evaluation
In an attempt to define the result of the operation a set of clinical, electrocardiographic and radiographic criteria were used. These included: 1) absence of symptoms, 2) absence of signs of cardiac failure or need for antifailure treatment, 3) absence of aortic diastolic murmurs, 4) normal pulse pressure, 5) reduction in cardiothoracic ratio as measured from a standard chest film, 6) decrease in electrocardiographic signs of LVH.
Patients were classified as excellent if all criteria were present, good if they were asymptomatic and all but one criterion present, fair if two or more criteria were lacking and poor if they had symptoms. The proportion of patients who were classified as excellent or good were grouped together and expressed as a percentage of the total number of patients followed up for different periods ( fig. 7) . Six years after operation 90% were judged to be excellent or good ( fig. 7) . There was no deterioration in the symptomatic status with passage of time ( fig. 7 ).
Electrocardiographic Changes
Complete regression of signs of left ventricular hypertrophy was observed in 215 patients (65.5%). Signs of residual LVH were present in 66 patients (20.1%). Most of these patients had systemic hypertension. The electrocardiogram was unchanged in 15 patients (4.6%).
Left bundle branch block was present in 20 patients (6.2%); of these the abnormality was observed preoperatively in 12.
Perioperative myocardial infarction was seen in two patients who died early after operation. appeared to be related to the age of the donor. We believe that the methods of preparation, storage and insertion can greatly influence the long term performance of the valves. Aortic homografts continue to be our method of choice for all patients undergoing aortic valve replacement. However we feel that continued evaluation is required to define the performance of these valves for longer periods of time.
SUMMARY Twenty-three patients were evaluated by cardiac catheterization two to 12 months following aortic valve replacement with the porcine xenograft valve. These hemodynamic studies established a mean peak-to-peak systolic gradient across the prosthesis of 23 mm Hg with a range of 6-58 mm Hg. The mean effective orifice area was calculated to be 1.25 cm2. The effective orifice area in-SINCE THE ERA of prosthetic cardiac valves was opened in 1952 with the implantation of the caged ball prosthesis in the thoracic aorta by Hufnagel,' active investigation of new prosthetic models has continued because of dissatisfaction with the hemodynamic characteristics, the durability, or the thrombogenicity of previously available prostheses. Among the prosthetic valves presently under clinical investigation is the porcine xenograft aortic valve ( fig. 1 ). This prosthesis is a composite tissue valve composed of porcine aortic leaflets mounted on a flexible stent and pretreated with a tanning agent (glutaraldehyde). The glutaraldehyde produces a cross-linkage between the collagen molecules and thus increases tissue strength. While the ease of implantation and the very low thrombogenicity of this particular prosthesis have been substantiated by previous investigations,2 its long-term durability remains unproven and its hemodynamic characteristics in the aortic position are untested. The present study defines the hemodynamic characteristics of this prosthesis in the aortic position.
Methods
